154 related articles for article (PubMed ID: 34809669)
1. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
2. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
[TBL] [Abstract][Full Text] [Related]
3. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
Ooki A; Dinalankara W; Marchionni L; Tsay JJ; Goparaju C; Maleki Z; Rom WN; Pass HI; Hoque MO
Oncogene; 2018 Nov; 37(45):5967-5981. PubMed ID: 29980786
[TBL] [Abstract][Full Text] [Related]
6. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells.
Wan X; Ma D; Song G; Tang L; Jiang X; Tian Y; Yi Z; Jiang C; Jin Y; Hu A; Bai Y
J Bioenerg Biomembr; 2024 Jun; 56(3):323-332. PubMed ID: 38441855
[TBL] [Abstract][Full Text] [Related]
7. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy.
Khan AQ; Hasan A; Mir SS; Rashid K; Uddin S; Steinhoff M
Semin Cancer Biol; 2024 May; 100():1-16. PubMed ID: 38503384
[TBL] [Abstract][Full Text] [Related]
8. Androgen up-regulation of Twist1 gene expression is mediated by ETV1.
Khatiwada P; Kannan A; Malla M; Dreier M; Shemshedini L
PeerJ; 2020; 8():e8921. PubMed ID: 32296610
[TBL] [Abstract][Full Text] [Related]
9. Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.
Mimeault M; Batra SK
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):234-54. PubMed ID: 24273063
[TBL] [Abstract][Full Text] [Related]
10. Sex-determining region of Y chromosome-related high-mobility-group box 2 in malignant tumors: current opinions and anticancer therapy.
Cao SG; Ming ZJ; Zhang YP; Yang SY
Chin Med J (Engl); 2015 Feb; 128(3):384-9. PubMed ID: 25635436
[TBL] [Abstract][Full Text] [Related]
11. Assessing the distribution of cancer stem cells in tumorspheres.
Fotinós J; Marks MP; Barberis L; Vellón L
Sci Rep; 2024 May; 14(1):11013. PubMed ID: 38745039
[TBL] [Abstract][Full Text] [Related]
12. Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy.
Tazuma S; Sudo T; Ishikawa A; Yamaguchi A; Shibata Y; Ishida Y; Kuraoka K; Uemura K; Takahashi S; Tashiro H
Surg Today; 2024 Apr; ():. PubMed ID: 38637344
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived apoptotic extracellular vesicle-mediated intercellular communication promotes metastasis and stemness of lung adenocarcinoma.
He X; Ma Y; Wen Y; Zhang R; Zhao D; Wang G; Wang W; Huang Z; Guo G; Zhang X; Lin H; Zhang L
Bioact Mater; 2024 Jun; 36():238-255. PubMed ID: 38481566
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive exploration of twist1 to identify a biomarker for tumor immunity and prognosis in pan-cancer.
Wang Y; Li C; Jiang T; Yin Y; Wang Y; Zhao H; Yu L
Medicine (Baltimore); 2024 Apr; 103(15):e37790. PubMed ID: 38608058
[TBL] [Abstract][Full Text] [Related]
15. The multifaceted role of SOX2 in breast and lung cancer dynamics.
Hushmandi K; Saadat SH; Mirilavasani S; Daneshi S; Aref AR; Nabavi N; Raesi R; Taheriazam A; Hashemi M
Pathol Res Pract; 2024 Jun; 260():155386. PubMed ID: 38861919
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer research: tools, cell types, and molecular targets.
Liu AY
Front Oncol; 2024; 14():1321694. PubMed ID: 38595814
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma.
Diao X; Guo C; Li S
Thorac Cancer; 2023 Jan; 14(3):320-330. PubMed ID: 36507553
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M
Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534
[TBL] [Abstract][Full Text] [Related]
19. Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma.
Chen Y; Huang W; Ouyang J; Wang J; Xie Z
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769187
[TBL] [Abstract][Full Text] [Related]
20. SOX2 mediates metabolic reprogramming of prostate cancer cells.
de Wet L; Williams A; Gillard M; Kregel S; Lamperis S; Gutgesell LC; Vellky JE; Brown R; Conger K; Paner GP; Wang H; Platz EA; De Marzo AM; Mu P; Coloff JL; Szmulewitz RZ; Vander Griend DJ
Oncogene; 2022 Feb; 41(8):1190-1202. PubMed ID: 35067686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
